Clinical Trials on Diabetes Mellitus, Type II in New Zealand
Total 2245 results
-
Novartis PharmaceuticalsCompletedEfficacy and Safety of Vildagliptin in Combination With Glimepiride in Patients With Type 2 DiabetesDiabetes Mellitus, Type 2United States
-
TheracosCompletedType 2 Diabetes MellitusUnited States, Canada, Czechia, Denmark, Korea, Republic of, Mexico, Netherlands, Poland, Russian Federation, Taiwan
-
NGM Biopharmaceuticals, IncNGM Biopharmaceuticals Australia Pty LtdCompleted
-
Eli Lilly and CompanyCompletedType 1 Diabetes MellitusUnited States, Spain, Germany, Puerto Rico, Austria
-
National Institute of Diabetes and Digestive and...CompletedDiabetes Mellitus, Insulin-DependentUnited States
-
AstraZenecaCompletedType 2 Diabetes MellitusUnited States
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Sweden, United States, Mexico, South Africa, Russian Federation, France, Spain, Switzerland, Canada, Finland, New Zealand, Korea, Republic of, Thailand, Israel, Germany, Peru, Australia, Denmark, Italy, Ukraine, Greece, Puerto Rico, Guatemal... and more
-
Children's Hospital New Orleans, LAUnknownType1diabetesUnited States
-
SanofiCompletedType 2 Diabetes MellitusMexico, South Africa, United States, Mauritius, Spain, Turkey
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2United States
-
NovartisCompletedDiabetes Mellitus, Type 2United States
-
NovartisCompletedDiabetes Mellitus, Type 2United States
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2United States
-
Yale UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
AstraZenecaCompletedType 2 Diabetes MellitusUnited States, Puerto Rico, Germany, Hungary
-
Profil Institut für Stoffwechselforschung GmbHEuropean UnionCompletedDiabetes Mellitus Type 1Germany
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Canada
-
SanofiCompletedType 2 DiabetesUnited States, Canada, Brazil, Poland, Romania, Russian Federation, Ukraine
-
Sansum Diabetes Research InstituteMayo Clinic; Icahn School of Medicine at Mount Sinai; Harvard UniversityCompletedType 1 Diabetes | PregnancyUnited States
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Australia, Spain, Korea, Republic of, Hungary, Mexico, Italy, Poland, Argentina, Canada, Colombia, France, Germany, Japan, Peru, Romania, Sweden, United Kingdom
-
University at BuffaloKaleida HealthCompleted
-
Jaeb Center for Health ResearchNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus, Type IUnited States
-
National Institute of Allergy and Infectious Diseases...Immune Tolerance Network (ITN)Recruiting
-
AstraZenecaCompletedType 2 DiabetesUnited States, Canada, France, Mexico
-
TheracosCompletedType 2 Diabetes MellitusUnited States, Canada
-
PhaseBio Pharmaceuticals Inc.Completed
-
TheracosCompletedDiabetes MellitusUnited States
-
InLight SolutionsVeraLight, Inc.CompletedDiabetes Mellitus, Type 2 | Prediabetic StateUnited States
-
Jaeb Center for Health ResearchNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus, Type IUnited States
-
Profil Institut für Stoffwechselforschung GmbHCompleted
-
Diasome PharmaceuticalsIntegriumCompletedType 1 Diabetes MellitusUnited States
-
Neurovalens Ltd.University College Dublin; Clinical Trial Mentors; CS LifescienceActive, not recruitingType 2 DiabetesUnited States, Ireland
-
Duke UniversityNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
Sansum Diabetes Research InstituteNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Harvard... and other collaboratorsCompletedType 1 DiabetesUnited States
-
State University of New York at BuffaloNational Center for Advancing Translational Sciences (NCATS)CompletedDiabetes Mellitus, Type 2 | Diet, Healthy | Pre-diabetesUnited States
-
Brigham and Women's HospitalPatient-Centered Outcomes Research InstituteRecruitingType2Diabetes | ASCVDUnited States
-
AstraZenecaAstra Zeneca, Bristol-Myers SquibbCompletedType 1 Diabetes MellitusUnited States
-
Oramed, Ltd.IntegriumCompletedDiabetes Type 2United States
-
SanofiCompletedType 2 Diabetes MellitusGermany, Spain, United States, Canada, Czechia, Hungary, Mexico, Russian Federation
-
NovartisCompletedVildagliptin Compared to Pioglitazone in Combination With Metformin in Patients With Type 2 DiabetesDiabetes Mellitus, Type 2United States, Germany
-
University of VirginiaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); DexCom... and other collaboratorsCompletedType 1 Diabetes MellitusUnited States
-
University of VirginiaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); DexCom... and other collaboratorsCompletedType 1 Diabetes MellitusUnited States
-
VeroScienceCompletedType 2 DiabetesUnited States
-
Becton, Dickinson and CompanyCompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1United States
-
SanofiTerminated
-
Yale UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingObesity | type1diabetesUnited States
-
University at BuffaloJuvenile Diabetes Research FoundationCompleted
-
SanofiHanmi Pharmaceutical Company LimitedTerminatedType 2 Diabetes MellitusEstonia, Spain, Ukraine, Italy, Germany, Canada, Mexico, United States, Argentina, Bulgaria, Chile, Denmark, Finland, Hungary, India, Korea, Republic of, Latvia, Lithuania, Norway, Peru, Poland, Romania, Russian Federation, Serbia, Slov... and more
-
Eli Lilly and CompanyActive, not recruitingType 2 DiabetesUnited States, Japan, China, India, Mexico, Puerto Rico
-
SanofiCompletedType 2 Diabetes MellitusFrance, Russian Federation, United States, Argentina, Canada, Germany, South Africa, Italy, Netherlands, United Kingdom, Australia, Chile